Julphar attributed losses to temporary suspension in the export of medicines to Saudi Arabia, Oman, Bahrain and Kuwait as well as product recalls due to quality issues. Jeff Topping / The National
Julphar attributed losses to temporary suspension in the export of medicines to Saudi Arabia, Oman, Bahrain and Kuwait as well as product recalls due to quality issues. Jeff Topping / The National

Economy

Julphar chief executive steps down as company faces mounting pressure

The company did not give a reason for Jerome Carle's departure from the firm

Sarmad Khan
Sarmad Khan

September 16, 2019